424B3 1 a2104307z424b3.htm 424B3
QuickLinks -- Click here to rapidly navigate through this document

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-75862

Prospectus Supplement No. 9 To
Prospectus Dated February 14, 2002

CUBIST PHARMACEUTICALS, INC.

$165,000,000 5 1/2% CONVERTIBLE SUBORDINATED NOTES DUE 2008
SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION THEREOF

        This prospectus supplement relates to the resale by the selling securityholders of Cubist Pharmaceuticals, Inc. 5 1/2% Convertible Subordinated Notes Due 2008 or shares of Cubist Pharmaceuticals, Inc. common stock issued upon conversion of the subordinated notes.

        This prospectus supplement should be read in conjunction with the prospectus dated February 14, 2002 and the prospectus supplements dated March 14, 2002, March 29, 2002, April 10, 2002, May 7, 2002, May 28, 2002, July 2, 2002, November 19, 2002 and December 30, 2002 and is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any amendments or supplements thereto.

        The following table supplements the information set forth in the prospectus under the caption "Selling Securityholders" with respect to the selling securityholders and the respective principal amount of notes which are beneficially owned and may be sold by each selling securityholder pursuant to this prospectus, as amended or supplemented. All information concerning beneficial ownership has been furnished by the selling securityholders.

Name and Address of Beneficial Owner
  Principal Amount Of Subordinated Notes Beneficially Owned That May Be Sold
  Percentage of Subordinated Notes Outstanding
  Number of Shares Of Common Stock That May Be Sold
CONTEXT CONVERTIBLE ARBITRAGE FUND, LP
12626 High Bluff Drive
San Diego, CA 92130
  $ 500,000   *   (1)

*
Less than 1% of the outstanding notes

(1)
Consists of a number of indeterminable shares of common stock as may be issued from time to time upon conversion of the subordinated notes, including such shares as may be issuable by reason of adjustment of the conversion price as a result of stock splits, stock dividends and similar anti-dilution provisions.

INVESTING IN THE SECURITIES INVOLVES RISKS. SEE "RISK FACTORS" BEGINNING
ON PAGE 7 OF THE PROSPECTUS.


        THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

        THE SECURITIES MAY BE SOLD FROM TIME TO TIME BY THE SELLING SECURITYHOLDERS OR THEIR DONEES, PLEDGEES, TRANSFEREES AND OTHER SUCCESSORS IN INTEREST IN ONE OR MORE TRANSACTIONS AT FIXED PRICES, AT MARKET PRICES AT THE TIME OF SALE, AT VARYING PRICES DETERMINED AT THE TIME OF SALE OR AT NEGOTIATED PRICES.

THE DATE OF THIS PROSPECTUS SUPPLEMENT IS FEBRUARY 25, 2003




QuickLinks

CUBIST PHARMACEUTICALS, INC.
$165,000,000 5 1/2% CONVERTIBLE SUBORDINATED NOTES DUE 2008 SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION THEREOF